NCT02561000View on ClinicalTrials.gov

Safety of PZ-128 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 27, 2016

Primary Completion Date

September 17, 2019

Study Completion Date

September 17, 2019

Conditions
Arterial Occlusive DiseasesCoronary Artery DiseaseCoronary DiseaseArteriosclerosisHeart DiseasesMyocardial IschemiaVascular DiseasesAcute Coronary Syndrome
Interventions
DRUG

PZ-128

DRUG

Placebo

Trial Locations (3)

22042

Inova Heart and Vascular Institute, Inova Fairfax Hospital, Falls Church

02111

Tufts Medical Center, Boston

01605

UMass Memorial Medical Center, Worcester

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

RTI International

OTHER

collaborator

Inova Fairfax Hospital

OTHER

collaborator

University of Massachusetts, Worcester

OTHER

lead

Tufts Medical Center

OTHER

NCT02561000 - Safety of PZ-128 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention | Biotech Hunter | Biotech Hunter